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1,3-Butadiene is used in the manufacture
ofsynthetic rubbers (such as styrene-buta-
diene rubber or poly-butadiene rubber)
and thermoplastic resins (1). Approxi-
mately 3000 million pounds of butadiene
are produced in the United States each
year (2). NIOSH estimates that approxi-
mately 9500 workers in the United States
are occupationally exposed to 1,3-butadi-
ene (1).
The International Agency for Research
on Cancer (IARC) reviewed the literature
on butadiene in 1992 and concluded that
there is "limited evidence" of the carcino-
genicity ofbutadiene in humans and "suf-
ficient evidence" of the carcinogenicity of
butadiene in experimental animals based
on three long-term animal bioassays (3).
Epidemiologic studies have been conduct-
ed among workers exposed to butadiene in
the manufacture ofstyrene-butadiene rub-
ber (4-) and among workers involved in
the production of butadiene monomer
(8-10). Meinhardt et al. (4,5) examined
mortality among 2756 white males
employed in two styrene-butadiene rubber
production facilities in Port Neches,
Texas. Elevated, although not statistically
significant, increased mortality was
observed for lymphatic and hematopoietic
neoplasms at one of the two plants [stan-
dardized mortality ratio (SMR) = 155], in
particular lymphosarcoma and reticulosar-
coma (SMR = 181) and leukemia (SMR =
203). These excesses were most pro-
nounced among workers hired during
World War II. Matanoski et al. (6) ana-
lyzed the mortality experience of 13,920
rubber production workers in the United
States and Canada and found no signifi-
cant increase in mortality from lymphatic
or hematopoietic cancer, or any other can-
cer site. However, a nonsignificant excess
risk of "other lymphatic cancer" (SMR =
202) was noted among production work-
ers. An update of this study was reported
by Matanoski et al. in 1990 (7). As in the
earlier study, there was no significant
increase in lymphatic or hematopoietic
cancer, or any other cancer site. Produc-
tion workers had a significant excess of
"other lymphatic cancer" (SMR = 260). A
significant excess ofall lymphopoietic can-
cers was noted for blacks (SMR = 507). A
nested case-control study oflymphopoiet-
ic cancer was conducted within this
cohort. This study examined lymphopoi-
etic cancer risk in relation to indices of
cumulative butadiene and styrene expo-
sure, and found a significant excess risk of
leukemia associated with butadiene expo-
sure (11).
Only one previous study has examined
the mortality experience ofbutadiene pro-
duction workers (8-10). This study
included 2586 male workers employed at a
facility located in Port Neches, Texas, for
at least 6 months between 1943 and 1979.
Butadiene was produced by the catalytic
dehydrogenation of n-butane. The first
analysis of the cohort by Downs et al.
found eight deaths from lymphosarcoma
and reticulosarcoma, yielding a significant
SMR of 235 compared to national rates;
the SMRwas 185 and nonsignificant com-
pared to county rates. In the update by
Divine et al. (9), there was one additional
lymphosarcoma and reticulosarcoma death
yielding a significant SMR of 229 (CI =
104-435; county-based SMR's were not
reported). In a third update (10), the SMR
for lymphosarcoma and reticulosarcoma in
the total cohort was not significant (n = 9;
SMR = 209; 95% CI = 95-396). How-
ever, among the subset of 1056 workers
with routine exposure to 1,3-butadiene,
there were 6 deaths from lymphosarcoma
and reticulosarcoma (SMR = 452; 95% CI
= 165-984).
To investigate the carcinogenic effects
of exposure to butadiene in humans, a
cohort of workers employed in butadiene
units was identified from within a large
cohort (29,139 workers) of chemical
workers whose mortality experience has
previously been reported (12). Rinsky et
al. analyzed the mortality experience ofthe
overall cohort without regard to particular
exposures (12). The primary hypothesis of
the current study was that exposure to
butadiene is associated with excess mortali-
ty from malignant neoplasms of the lym-
phatic and hematopoietic tissue. A sec-
ondary hypothesis was that butadiene
would cause excess mortality from neo-
plasms ofother sites.
Background
The study population was identified from
records of 29,139 workers at three Union
Carbide Corporation facilities in the
Kanawha Valley, West Virginia: the South
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Charleston plant, the Institute plant, and
the Technical Center. The first two of
these facilities produced butadiene and are
included in this study. The South
Charleston plant began operations in
1925, around the process ofstripping eth-
ylene from natural gas. It evolved into a
chemical and plastics facility, producing a
wide variety of chemical substances,
including butadiene, ethylene oxide, poly-
ethylene, vinyl chloride resins, and polyols.
The Institute plant was originally built by
the U.S. government (U.S. Rubber Reserve
Corporation) to produce styrene-butadiene
rubber to replace the supply ofnatural rub-
ber that was cut offduring World War II.
This facility was bought by Union Carbide
in 1947. The plant was then used as a larg-
er production facility for materials devel-
oped at the South Charleston plant, such
as acetone, isopropanol, butanol, and
acetaldehyde. As of 1986, when the
Institute plant was sold to Rhone-Poulenc,
it had expanded to include the manufac-
ture of agricultural chemicals and a wide
range of ethylene oxide and propylene
oxide-based products.
Butadiene production units were iden-
tified from a chemical and department
index developed by Union Carbide. The
index listed all products, by-products, and
reactants for each chemical production
unit within the South Charleston and
Institute plants. Departments were identi-
fied where butadiene was a primary prod-
uct and neither benzene nor ethylene oxide
was present.
South Charleston (1941-1965). The
butadiene production process at South
Charleston involved the recovery ofbutadi-
ene monomer from olefin cracking (see
appendix for process description). Among
the chemicals used in the process was bis(2-
chloroethyl)ether, which also has been eval-
uated by IARC for carcinogenicity. The
IARC regards bis(2-chloroethyl)ether as
having limited evidence of carcinogenicity
in animals (13,14), based on a bioassay in
which an excess ofhepatomas was observed
in mice (15). This chemical showed nega-
tive results in a bioassay measuring pul-
monary tumor response in mice (16) and in
along-term bioassay in rats (17).
Rubber Reserve Unit, Institute plant
(1943-1946). The U.S. Rubber Reserve
Corporation butadiene production unit
operated from 1943 to 1946 at the
Institute plant. The unit produced butadi-
ene monomer indirectly from ethanol (see
appendix for process description). As in the
South Charleston unit, bis(2-chloro-
ethyl)ether was used in this process. In
addition, large quantities of acetaldehyde
were present. Acetaldehyde is considered by
IARC to have "sufficient evidence" of car-
cinogenicity in animals (18) based on its
ability to induce tumors of the larynx and
nasal epithelium in hamsters (19) and rats
(20).
Institute plant (1959-1971). The
Institute plant also produced butadiene
monomer as a by-product of olefin crack-
ing from 1959 to 1971. The process was
the same as described for the butadiene
production units at the South Charleston
plant; however, in 1965 dimethyl
acetamide was substituted for bis(2-
chloroethyl)ether.
Methods
The study population was identified by
searching a computer file of work history
records of 29,139 workers included in a
mortality study of males employed from
1940 to 1979 at any ofthe Union Carbide
chemical plants operating in the Kanawha
Valley (12). The computer file ofwork his-
tory records contained a code representing
each department in which an individual
worked, but not the starting or ending
dates. A total of527 individuals were iden-
tified as having ever worked in the depart-
ment codes relating to the butadiene units
in the South Charleston or Institute plants
identified for study. Copies of personnel
records were collected for these individuals,
and the starting and ending dates of their
employment in each department were
coded. Only 364 individuals who worked
in the departments during the years when
butadiene was produced were retained in
the study (n = 364). As in the overall
Kanawha Valley chemical workers cohort,
there was a high proportion ofindividuals
whose race was unknown (28%). Among
those whose race was known, 94% were
white. Therefore, individuals whose race
was unknown were assumed to be white.
The Rinsky et al. (12) Kanawha Valley
study determined vital status through 31
December 1978. For individuals not
known to be deceased as ofthat date, vital
status through 31 December 1990 was
determined by matching with records of
the National Death Index (NDI).
Individuals known to be alive as of 31
December 1978 who were not identified as
deceased from National Death Index
records 1979-1990 were assumed alive as
of 31 December 1990. For workers who
were deceased, death certificates were
obtained from state vital statistics offices
and were coded according to the
International Classification of Diseases
(ICD) revision in effect at the time of
death. The mortality experience of the
cohort was compared to United States and
to Kanawha County mortality rates using a
modified life-table analysis system (LTAS)
developed by NIOSH (21,22). The county
rate analysis was restricted to the time peri-
od 1960 through 1990 for which county
referent rates are available in the NIOSH
lifetable. Standardized mortality ratios,
95% confidence intervals, and two-sidedp-
values were calculated. Confidence inter-
vals andp-values were calculated using an
exact method (if either the observed or
expected was less than 6) or an approxi-
mate method (if observed or expected fre-
quencies were 6 or more). Because of the
small size of the cohort and therefore the
small numbers ofdeaths, latency and dura-
tion analyses were performed by simply
dichotomizing both latency and duration
categories so that approximately equal
numbers of expected deaths were below
and above the cutpoints.
For specific cancer site categories in
which a statistically significant elevated
SMR was observed, concomitant chemical
exposures of the deceased workers were
identified. This was accomplished by list-
ing all departments other than butadiene
in which their personnel records indicated
they worked and then identifying the
chemicals used and produced in each
department from the index assembled by
Union Carbide.
Results
Among the 364 persons who were identi-
fied as working in any of the butadiene
production units, 277 individuals worked
in the Rubber Reserve Unit which pro-
duced butadiene from ethanol, and 87
worked in the units at the South
Charleston and Institute plants which pro-
duced butadiene from olefin cracking.
Among these 364 persons, 176 (48.3%)
were alive, 185(50.8%) were deceased, and
3 (0.8%) had unknown vital status as of
the study end date of 31 December 1990.
Table 1 shows the mortality pattern ofthe
total cohort through 1 January 1990 based
on U.S. referent rates. As in the previous
study ofthe mortality experience of29,139
workers in the three Kanawha Valley
plants through 1978 (3), the SMR for
deaths from all causes in the butadiene
production cohort was <1.00. The SMR
for deaths from all malignant neoplasms
was 1.05 (CI = 0.78-1.40), which was
higher than the SMR for deaths from all
malignant neoplasms in the larger chemical
workers cohort (SMR = 0.93; CI =
0.88-0.99) (12). Among the 92 specific
causes of death and 26 major categories
examined in the NIOSH lifetable, there
was only one significantly elevated SMR,
which was for the category "lymphosarco-
ma and reticulosarcoma" (n = 4; SMR =
5.77; CI = 1.57-14.8). County-based
analyses, which covered only the time peri-
od 1960-1990, resulted in a similar SMR
(SMR = 5.78; CI = 1.57-14.8).
Table 2 provides the SMRs for lym-
phosarcoma and reticulosarcoma by dura-
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Table 1. Mortality (through 31 December 1990)from specific causesfor butadiene production workers
Cause Observed Expected SMR 95% Cl
Tuberculosis 0 1.72
Malignant neoplasms
Buccal and pharynx 1 1.29 0.77 0.02-4.29
Digestive organs 11 12.2 0.90 0.45-1.61
Stomach 5 2.06 2.41 0.79-5.68
Respiratory system 19 16.6 1.14 0.69-1.79
Trachea, bronchus, and lung 19 15.8 1.20 0.72-1.88
Male genital organs 3 3.70 0.81 0.17-2.37
Urinary organs 1 2.32 0.43 0.01-2.39
Lymphatic and hematopoietic 7 3.99 1.75 0.70-3.61
Lymphosarcoma and reticulosarcoma 4 0.69 5.77 1.57-14.8
Hodgkin's disease 0 0.34
Leukemia and leukemia 2 1.62 1.23 0.15-4.44
Other lymphatic or hematopoietic 1 1.33 0.75 0.02-4.17
Other sites 6 5.36 1.12 0.41-2.44
Neoplasms of benign and 0 0.62
unspecified nature
Diabetes melitis 2 2.90 0.69 0.08-2.49
Blood and blood-forming diseases 0 0.54
Alcoholism and mental disorders 0 1.21 -
Nervous system diseases 1 2.14 0.47 0.01-2.59
Diseases ofthe heart 75 82.2 0.91 0.72-1.14
Diseases ofthe circulatory system 21 18.2 1.15 0.71-1.76
Respiratory system diseases 7 13.9 0.50 0.20-1.03
Digestive system diseases 5 9.36 0.53 0.17-1.25
Diseases of genitourinary system 2 2.96 0.68 0.08-2.44
Diseases ofthe skin and 0 0.17
subcutaneous tissue
Musculoskeletal diseases 0 0.35
Symptoms and ill-defined conditions 2 2.48 0.81 0.09-2.91
Accidents 10 10.3 0.97 0.46-1.78
Suicide and homicide 3 4.62 0.65 0.13-1.90
All other causes 3 2.88 1.04 0.21-3.04
Certificates not obtained 6
All cancers 48 45.5 1.05 0.78-1.40
All causes 185 202.2 0.91 0.79-1.06
SMR, standarized mortality ratio.
Table 2. Standardized mortality ratios (SMRs) forlymphosarcoma and reticulosarcoma by duration of
employment and time since firstemployment in butadiene production processes
Duration ofemploymentsb
< 2years 2 2 years Total
Latencya Observed SMR Observed SMR Observed SMR
< 30years 1 4.92 0 1 2.41
230 years 0 3 19.8** 3 10.8**
Total 1 3.03 3 8.27* 4 5.77*
aLatency categories were selected to divide expected deaths from all causes into two approximately
equal categories. There were 95 expected deaths in the < 30 years latency category and 107 in the 2 30
rears latency category.
Duration of employment categories were selected to divide expected deaths from all causes into two
approximately equal categories. There were 100 expected deaths in the < 2 years duration category and
102 in the .2years duration category.
*p< 0.05; **p < 0.01.
tion of employment in butadiene produc-
tion processes and latency (defined as time
since first employment in butadiene pro-
duction processes). Three of the four
deaths from lymphosarcoma and reticu-
losarcoma occurred in the >2 years' dura-
tion and >30 years' latency categories
(SMR = 19.8; CI = 4.08-57.8). Table 3
provides additional information about the
work histories ofthe four individuals, three
of whom worked in the Rubber Reserve
unit at the Institute plant. Aside from their
assignments to butadiene production units,
there were no commonalities among the
four cases except that two had been
assigned to an acetaldehyde unit, one for 8
years and one for 29 years.
There was a statistically nonsignificant
excess of stomach cancer in the overall
cohort (n = 5; SMR = 2.43; CI = 0.79-5.68)
that was most pronounced among workers
employed in the Rubber Reserve plant for
over 2 years (n = 5; SMR = 6.57; CI =
2.13-15.3; Table 4). County-based analyses
for the overall cohort showed identical
SMRs of2.93 for the county and U.S. refer-
ent rates 1960-1990. Table 5 provides
information about the work histories ofthe
five individuals who died of stomach can-
cer. Aside from their assignments to the
butadiene unit, the only commonality
among the work histories of the cases was
that two had been assigned to "mainte-
nance ofgrounds."
Discussion
The major finding of this study is excess
mortality from lymphosarcoma and reticu-
losarcoma among workers employed in
butadiene production processes located
within two large chemical plants. An
excess of lymphosarcoma and reticulosar-
coma (SMR = 239) was observed in the
only other butadiene production cohort
previously studied (8-JO). The latter plant
used a different process (the catalytic and
oxidative dehydrogenation of n-butane)
from either of the two processes used by
Union Carbide. A nonsignificant excess in
lymphosarcoma and reticulosarcoma
deaths was also found at one oftwo plants
producing styrene-butadiene rubber (4).
Elevated lymphoma incidence has also
been observed in mouse bioassays (23-26).
A prior mortality study of workers at
the Union Carbide's Kanawha Valley
plants found a significant excess of lym-
phosarcoma and reticulosarcoma (SMR =
1.40; CI = 104-187) (12). An excess of
deaths from this cause in the county where
the plant is located (Kanawha County,
West Virginia) has been noted previously
(27. The county rate analyses in the cur-
rent paper show that the expected number
of deaths for lymphosarcoma and reticu-
losarcoma are approximately 15% higher
in Kanawha County than in the U.S. pop-
ulation. Thus, geographical variation does
not explain a substantial proportion ofthe
increased risk among workers in butadiene
units. A previous study which evaluated
occupational risk factors for lymphopoietic
cancers within Union Carbide's Kanawha
Valley plants did not specifically evaluate
the risks for lymphosarcoma and reticu-
losarcoma, but instead included these
tumors in the broader grouping, "non-
Hodgkin's lymphoma" (28). That study
did not find an association between buta-
diene exposure and non-Hodgkin's lym-
phoma. Those results cannot be directly
compared to findings of the current study
because the periods of case ascertainment,
disease groupings, and classification of
butadiene exposure were different.
Ourstudy also found an excess ofstom-
ach cancer among workers employed in the
Rubber Reserve Unit for over 2 years.
Review ofthe work histories ofall the indi-
viduals who died ofstomach cancer did not
reveal any likely confounding exposures.
Stomach cancer was in deficit in the overall
Kanawha Valley chemical worker cohort
followed through 1978 (SMR = 79; CI =
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Table 3. Work histories of individuals who died of lymphosarcoma and reticulosarcoma
Approximate length
Beginning year of employment Time from Butadiene
Age at death of employment in butadiene initial exposure Year department Other departments/
(years) in butadiene unit (months) to death (years) of death worked in exposures
65 1942 39 33 1975 Rubber reserve Acetaldehyde unit,a outsidework
64 1943 35 36 1979 Rubber reserve Maintenance ofgrounds,
acetaldeh de unitaupperisland
chemicals
52 1946 9 25 1971 Rubber reserve Isopropanol-acetone,C
laborer, maintenance, general
stores and purchasing
63 1952 96 32 1984 Olefin unit, Maintenance labor, gasplants/
S. Charleston olefins,doutsidework, acetylene
unit,Cweighmaster, chemicals
and resins-packaging and shipping
aAcetaldehyde unit: A variety of chemicals, many requiring acetaldehyde as a reaction material, were produced in this department. These included vinyl
isobutyl ether, vinyl ethyl ether, vinyl butyl ether, vinyl methyl ether, hexaldehyde, 2-ethyl butyraldehyde, propionaldehyde, 2-methyl pentaldehyde, methyl
isoamyl ketone, 2,3-dimethyl pentaldehyde, ethyl propenal ether, ethyl acetate, and 2-methyl pentaldehyde. Refined acetaldehyde was also produced.
bUpper island chemicals area units: A large variety of chemicals, including ethers, ketones, alcohols, and acids were produced in these units.
Clsopropanol-acetone department: Materials handled in this department included propylene, diisopropanol sulfate, fuel gas, water, sulfuric acid, and "merrill
oil." Products included isopropanol, diisopropyl ether, isopropyl oils, and weak sulfuric acid.
dGas plants/olefins: Materials handled in this department included butane, propane, acetone, gasoline, butadiene vent gas, methanol, blowbacks from ethylene
absorbers at "MB," polyethylene, chlorohydrin, propylene absorbers from isopropanol, caustic 20%, anti-oxidant, "DuPont No. 5," wood chips, and alumina pel-
lets. Products included ethylene, propylene, and acetylene. By-products included crude butadiene, propane, "pyrofax," benzene, hydrogen-methane, sulfur sat-
urated wood chips, hydrogen, and residues.
eAcetylene unit: Process materials included calcium carbide, sodium hydroxide, and sulfuric acid. Products included acetylene and calcium hydroxide.
59-104) (12). Prior epidemiologic studies
of butadiene-exposed workers have report-
ed a decreased SMR for digestive cancers
overall (4), a decreased SMR for stomach
cancer (8-J1) and a slightly elevated SMR
(1.05) for stomach cancer which was higher
among black workers (SMR = 1.45) and
maintenance workers (SMR = 1.51) (7).
Carcinomas of the forestomach have been
found to be elevated in two mouse bioas-
says of1,3-butadiene (23-26).
The current study has several limita-
tions. One limitation is that cancer mortal-
ity, rather than incidence, was considered,
and thus any increased risk at cancer sites
with high survival rates might not be
detected. This limitation could not be
readily overcome because there is no popu-
lation-based cancer registry in the
Kanawha Valley area. It is not known
whether there are living individuals in the
cohort who have been diagnosed with lym-
phosarcoma or reticulosarcoma. An impor-
tant limitation is the potential for con-
founding exposure both within the butadi-
ene production units and outside the units.
We attempted to address the issue of con-
founding in the design of the study by
selecting a priori only departments where
butadiene was a primary product and ben-
zene and ethylene oxide were not present.
We also identified potential confounding
exposures outside the butadiene units by
examining the work histories of cases to
determine whether there were common
exposures. Among the potential confound-
ing exposures which could not be con-
trolled for in the study design, acetalde-
hyde was of the greatest concern both
Table 4. Standardized mortality ratios (SMRs) for malignant neoplasms of the stomach by duration of
employment and time since first employment in the rubber reserve plant
Duration ofemploymentb
< 2years 22 years Total
Latencya Observed SMR Observed SMR Observed SMR
<30years 0 2 5.63 2 2.25
230years 0 - 3 7.40 3 3.69
Total 0 5 6.57* 5 2.94*
aLatency categories were selected to divide expected deaths from all causes into two approximately
equal categories. There were 73 expected deaths in the < 30 years latency category and 91 in the 2 30
rears latency category.
Duration of employment categories were selected to divide expected deaths from all causes into two
approximately equal categories. There were 87 expected deaths inthe < 2 years duration category and 77
in the .2 years duration category.
*p< 0.01.
because it was present in the rubber reserve
process and because two of the four indi-
viduals who died of lymphosarcoma and
reticulosarcoma worked in the acetalde-
hyde unit. In addition, a case-control
study ofrisk factors for lymphopoietic can-
cer within Union Carbide's Kanawha
Valley chemical plant (28) found an elevat-
ed odds ratio for non-Hodgkin's lym-
phoma associated with exposure to
acetaldehyde, but noted that odds ratios
and duration trends were similar for
acetaldehyde and acrylonitrile because of
concomitant use ofthe two chemicals.
To examine further whether the risk of
lymphosarcoma and reticulosarcoma might
be attributable to an elevated risk associat-
ed with the acetaldehyde unit, to which
two ofthe four cases had been assigned, we
identified 233 workers from the large
cohort of 29,139 who had ever been
assigned to this unit and followed their
mortality through 1991. A total of 48
deaths were identified. Aside from the two
deaths from lymphosarcoma and reticu-
losarcoma previously identified among
workers who had been included in the
butadiene production study, there were no
other deaths from this cause.
The toxicologic data are consistent
with the conclusion that the excess oflym-
phosarcoma and reticulosarcoma found in
the study are likely to be related to butadi-
ene rather than confounding exposure to
acetaldehyde. Acetaldehyde has only been
demonstrated to induce upper respiratory
tumors in rodents at levels (1000 ppm and
above) substantially above the levels at
which acetaldehyde has been demonstrated
to cause eye irritation in humans (29). In
contrast, butadiene has been shown to
cause an increase in incidence of lympho-
cytic lymphomas and histiocytic sarcomas
in mice (formerly known as type A reticu-
lum cell sarcomas) at concentrations as
low as 200 ppm, with marginally signifi-
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Table 5. Work histories of individuals who died of stomach cancer
Beginning year Approximate length Timefrom Butadiene
Age atdeath ofemployment in ofemployment initial exposure Year department
(years) butadiene unit in butadiene (months) to death (years) ofdeath worked in Otherdepartments/exposures
75 1943 37 21 1964 Rubber reserve None
67 1944 30 18 1962 Rubber reserve None
65 1943 42 33 1976 Rubber reserve Maintenance ofgrounds, polyethylene department
65 1943 54 33 1976 Rubber reserve Gas plants/olefinsb
and S. Charleston
74 1943 29 32 1975 Rubber Reserve Maintenance ofgrounds,janitors and watchmen,
general maintenance, building services, and guards
a"Dowtherm," "Ucon," "Heat transfer fluid 500," butyl hydroxy toluene, "Super floss" and "Vazo." Products were various grades of homopolymers and copoly-
mers, recovered vinyl acetate, unreacted ethylenes, and oils.
bGas plants/olefins: Materials handled in this department included butane, propane, acetone, gasoline, butadiene vent gas, methanol, blowbacks from ethylene
absorbers at "MB," polyethylene, chlorohydrin, propylene absorbers from isopropanol, caustic 20%, anti-oxidant, "DuPont No. 5," wood chips, and alumina pel-
lets. Products included ethylene, propylene, and acetylene. By-products included crude butadiene, propane, "pyrofax," benzene, hydrogen methane, sulfur satu-
rated wood chips, hydrogen, and residues.
cant increases in histiocytic sarcomas down
to 20 ppm (24,25).
When studying workers employed at
large chemical production complexes, it is
impossible to rule out the potential impor-
tance of confounding exposures. Ott et al.
(28) noted that the average production
worker at these plants was exposed to 58
different chemicals, many of which were
correlated. Other studies conducted in the
same chemical worker population have
identified associations of lymphosarcoma
and reticulosarcoma with maintenance
(Teta J, unpublished data) and strong acid
ethanol production (30), and the broader
category non-Hodgkin's lymphoma with
units using acetaldehyde (28). These obser-
vations were made in efforts to investigate
the observed excess ofdeath for the original
cohort study of 29,139 workers or in sur-
veillance studies. The current study, on the
other hand, was initiated in 1986 to exam-
ine the hypothesis that exposure to butadi-
ene might be related to hematopoietic can-
cer. If exposure data were available, the
association between mortality from lym-
phosarcoma and reticulosarcoma might be
evaluated by determining whether there is
evidence for an exposure-response relation-
ship. However, there are no air monitoring
data for any of the butadiene production
processes, and thus air concentrations of
butadiene (and other chemicals) cannot be
estimated. Personnel records do not indi-
cate the types oftasks orjob assignments an
individual worker had; thus, there is no
way to know whether the four individuals
who developed lymphosarcoma or reticu-
losarcoma were exposed to higher concen-
trations of butadiene than other members
of the cohort. Finally, the U.S. Rubber
Reserve plant operated for only 4 years, and
thus we could not evaluate the effects of
prolonged exposure to this process.
Despite the limitations outlined above,
the study has demonstrated an excess of
mortality from lymphosarcoma and reticu-
losarcoma, which is consistent with the only
other butadiene production cohort previ-
ously studied. Finding an excess of neo-
plasms of the lymphatic system in relation
to butadiene exposure is consistent with the
mouse bioassay data as well (18,19). We
conclude that the results ofthis studyadd to
the weight of the evidence suggesting that
butadiene is carcinogenic in humans.
Appendix. Process Description
Rubber Reserve Process: Production
ofButadiene from Ethanol (Institute
Plant, Early 1940s)
The rubber reserve plant was operated by
the Union Carbide Corporation during
World War II under contract with the U.S.
government. The rubber reserve process
produced butadiene indirectly from ethanol.
To better understand the process, the plant
may be considered as being composed of
four major divisions: 1) an acetaldehyde
conversion system, 2) a butadiene conver-
sion system, 3) a butadiene purification sys-
tem, and 4) a recovery distillation system.
In the acetaldehyde conversion system,
the ethanol was introduced into a catalytic
converter containing a copper-chromium
catalyst and was partially converted to
acetaldehyde. The converters were heated
by circulating liquid Dowtherm. The reac-
tion involved was
Ethanol -> Acetaldehyde + Hydrogen
Cu - Cr
In this step, side reactions occurred that
resulted in the formation of acetic acid,
ethyl acetate, butylaldehyde, and butanol.
The equipment in the butadiene con-
verter system is similar to that used in the
acetaldehyde conversion system. The
process was as follows:
Ethanol + Acetaldehyde -* Butadiene + Water
Titanium Oxide
In passing through the titanium oxide, the
combined ethanol and acetaldehyde are
15-20% converted to butadiene at an effi-
ciency of60-65%. Conversion ofthis mix-
ture resulted in the formation of a large
number ofby-products. Among these were
ethylene, ethane, propylene, propane,
butylene, butane, carbon dioxide, carbon
monoxide, diethyl ether, butyraldehyde,
ethyl acetate, methyl ethyl ketone, carbon,
acetic acid, butanol, and other unidentified
hydrocarbons.
The major process steps in the purifica-
tion phase were as follows: 1) stripping the
crude butadiene from the condensed liq-
uids of the butadiene converters, 2)
removal of acetaldehyde from the butadi-
ene, and 3) removal of butane and buty-
lene from the butadiene.
The crude butadiene was removed
from the condensate collected from the
catalytic converter by distillation in a heat-
ed column. The crude butadiene at this
point is a mixture ofbutenes, butane, and
the binary azeotrope of butadiene and
acetaldehyde. The crude mixture, includ-
ing the azeotrope with acetaldehyde, was
passed through a water scrubber to absorb
the acetaldehyde present in the vapor. The
acetaldehyde-free vapor from the scrubber
was then fed to another column and the
butadiene was absorbed by Chlorex (di-2-
chloroethyl ether). The Chlorex preferen-
tially absorbed the butadiene and allowed
the butylenes and butane to pass out ofthe
column. The remaining vapors consisted
largely of butadiene, water, and some
Chlorex. Chlorex, when heated, breaks
down and forms dilute hydrochloric acid.
Caustic soda was used in the solvent sys-
tem to neutralize the hydrochloric acid.
The final step in the purification process
required the water and the Chlorex to be
condensed and separated. The resulting
product is butadiene at a purity of99.5%.
The function of the recovery distilla-
tion system was to reconcentrate the unre-
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acted acetaldehyde and ethanol from the
conversion system, remove the by-products
from the material cycle and to feed the
converters.
Union Carbide Process: Recovery of
Butadiene from Olefin Cracking
(Institute Plant, 1959-1971 and
South Charleston Plant,
1941-1965)
The Union Carbide olefin unit used a
high-temperature cracking process to pro-
duce ethylene from hydrocarbons. The
process was developed to recover butadiene
as a by-product of the normal ethylene
process. The relatively pure mixture ofthe
four carbon molecules (less than 50%
butadiene) was supplied from three sources
in 10,000-gallon capacity feed tanks.
Crude feed from the feed tanks was fed
to an absorber column, and Chlorex was
the solvent used to desorb the butadiene.
The Chlorex, after absorption ofthe major-
ity of the butadiene, was routed to a strip-
ping column. The crude butadiene at this
phase of the process was 88-90% pure.
The material was then scrubbed with water
to remove any aldehydes which might have
been present. The condensed, partially
refined butadiene was then compressed and
piped to the 10,000-gallon capacity inter-
mediate storage tanks prior to recracking.
To control the formation of popcorn-type
polymers, sodium nitrite was added to the
process stream to remove the oxygen.
Final refining ofbutadiene was a distil-
lation process carried out in a two-column
system. The 88-90% butadiene stream was
introduced to a fore column where vinyl
acetylene was removed from the process
stream. The butadiene was now 97% pure
and final purity of 99.5% was obtained
from the refined butadiene condenser and
then pumped to the refined storage tanks.
Before loading or shipping the final prod-
uct, Catechol (p-tertiary butyl catechol)
was injected into the product to inhibit
polymerization.
Subsequent process changes, 1965 and
later, used dimethyl acetamide as the
absorbent solvent in place ofChlorex.
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